Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Circulating microRNAs as biomarkers for disease staging in multiple sclerosis.
Apitope Announces Completion of Enrolment in Phase IIA Clinical Trial of ATX-MS-1467 in Relapsing Multiple Sclerosis
Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis.
Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.
Neuromyelitis optica.
First use of alemtuzumab in Balo's concentric sclerosis: a case report.
Helminth therapy and multiple sclerosis.
The American Academy of Neurology's Top Five Choosing Wisely recommendations.
Magnetic Resonance Imaging of Optic Neuritis in Patients With Neuromyelitis Optica Versus Multiple Sclerosis.
Time limited immunomodulatory functions of transplanted neural precursor cells.
Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.
Changes in JC Virus-Specific T Cell Responses during Natalizumab Treatment and in Natalizumab-Associated Progressive Multifocal Leukoencephalopathy.
Evaluation of an electronic diary for improvement of adherence to interferon beta-1b in patients with multiple sclerosis: design and baseline results of an observational cohort study.
Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis - a review.
Siponimod (BAF312) for the treatment of secondary progressive multiple sclerosis: Design of the phase 3 EXPAND trial.
Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial.
Calpain inhibition attenuated morphological and molecular changes in skeletal muscle of experimental allergic encephalomyelitis rats.
Oral therapies for multiple sclerosis: a review of agents in phase III development or recently approved.
Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis.
Neural differentiation of patient specific iPS cells as a novel approach to study the pathophysiology of multiple sclerosis.
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.
Mechanism of action, pharmacokinetics, adverse effects, and therapeutic uses of amiloride hydrochloride, a new potassium-sparing diuretic.
Natural History of Multiple Sclerosis Symptoms
Sera from remitting and secondary progressive multiple sclerosis patients disrupt the blood-brain barrier.
A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - A twelve month follow-up.

Pages